Assessment of availability and challenges of WHO recommended priority life-saving medicines for under five-year children in primary public health facilities of Amhara region.
Availability
Primary public health facility
Under five children
WHO priority medicine
Journal
BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804
Informations de publication
Date de publication:
09 08 2023
09 08 2023
Historique:
received:
02
02
2023
accepted:
27
07
2023
medline:
11
8
2023
pubmed:
10
8
2023
entrez:
9
8
2023
Statut:
epublish
Résumé
The world health organization (WHO) priority lifesaving medicines are medicines recommended for the prevention and treatment of leading causes of under-five morbidity and mortality. They should be available in all health systems and at all times. However, the availability of these medicines and its determinants is not well studied in Ethiopia in general and in primary public health facilities Amhara region in particular. The study aimed to assess the availability and challenges of the WHO-recommended priority lifesaving medicines for under-five children in primary public health facilities of the Amhara region. A cross-sectional study design was conducted from February to December 2020 in 98 health centers and 22 primary hospitals in the Amhara region, Ethiopia. Facilities were selected with a simple random sampling technique. The data were collected through a pretested and structured questionnaire. Binary logistic regression was used to identify predictors associated with availability of WHO-recommended priority lifesaving medicines for under-five children. The availability of oral rehydration salt was high (82.5%) and the availability of vitamin A (47.5%), morphine tablet (13.3%), and artesunate rectal suppository (7.5%) were within low and very low WHO range respectively. Budget adequacy (AOR = 12.9 CI= (2.1-78.2)), periodic review of stock level ((AOR = 13.4,CI=(1.9-92.0)), training on integrated pharmaceutical logistic system ((AOR = 4.5,CI=(1.0-20.5)), inclusion of WHO priority under five children facility specific medicine list (AOR = 12.4,CI=(2.3-66.4)), lead time for EPSA(Ethiopia Pharmaceutical Supply Agency) procurement (AOR = 7.9,CI=(1.3-44.8)) were significantly associated with availability of all WHO priority lifesaving medicines for under- five children. The average availability of WHO-recommended priority lifesaving medicines for under-five children was low. The habit of updating bincard and adoption of the life-saving medicine list were the independent predictors of medication availability.
Sections du résumé
BACKGROUND
The world health organization (WHO) priority lifesaving medicines are medicines recommended for the prevention and treatment of leading causes of under-five morbidity and mortality. They should be available in all health systems and at all times. However, the availability of these medicines and its determinants is not well studied in Ethiopia in general and in primary public health facilities Amhara region in particular.
OBJECTIVE
The study aimed to assess the availability and challenges of the WHO-recommended priority lifesaving medicines for under-five children in primary public health facilities of the Amhara region.
METHODS
A cross-sectional study design was conducted from February to December 2020 in 98 health centers and 22 primary hospitals in the Amhara region, Ethiopia. Facilities were selected with a simple random sampling technique. The data were collected through a pretested and structured questionnaire. Binary logistic regression was used to identify predictors associated with availability of WHO-recommended priority lifesaving medicines for under-five children.
RESULTS
The availability of oral rehydration salt was high (82.5%) and the availability of vitamin A (47.5%), morphine tablet (13.3%), and artesunate rectal suppository (7.5%) were within low and very low WHO range respectively. Budget adequacy (AOR = 12.9 CI= (2.1-78.2)), periodic review of stock level ((AOR = 13.4,CI=(1.9-92.0)), training on integrated pharmaceutical logistic system ((AOR = 4.5,CI=(1.0-20.5)), inclusion of WHO priority under five children facility specific medicine list (AOR = 12.4,CI=(2.3-66.4)), lead time for EPSA(Ethiopia Pharmaceutical Supply Agency) procurement (AOR = 7.9,CI=(1.3-44.8)) were significantly associated with availability of all WHO priority lifesaving medicines for under- five children.
CONCLUSION
The average availability of WHO-recommended priority lifesaving medicines for under-five children was low. The habit of updating bincard and adoption of the life-saving medicine list were the independent predictors of medication availability.
Identifiants
pubmed: 37558993
doi: 10.1186/s12887-023-04216-6
pii: 10.1186/s12887-023-04216-6
pmc: PMC10413804
doi:
Substances chimiques
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
395Informations de copyright
© 2023. BioMed Central Ltd., part of Springer Nature.
Références
Integr Pharm Res Pract. 2022 Sep 07;11:139-149
pubmed: 36105781
Am Fam Physician. 2021 Mar 15;103(6):355-364
pubmed: 33719377
Cochrane Database Syst Rev. 2018 Jun 05;6:CD007396
pubmed: 29870574
Cochrane Database Syst Rev. 2022 Mar 16;3:CD008524
pubmed: 35294044
Best Pract Res Clin Obstet Gynaecol. 2020 Aug;67:100-112
pubmed: 32265134
Risk Anal. 1995 Jun;15(3):369-90
pubmed: 7604170
Int J Gynaecol Obstet. 2006 Jun;93(3):285-91
pubmed: 16687145
Health Serv Res Manag Epidemiol. 2019 Dec 01;6:2333392819892350
pubmed: 31832490
BMC Pediatr. 2016 Mar 15;16:40
pubmed: 26979737
Nutrients. 2019 Mar 22;11(3):
pubmed: 30909386
Reprod Health. 2009 Apr 14;6:5
pubmed: 19366451
BMC Med Inform Decis Mak. 2018 Dec 17;18(1):133
pubmed: 30558596
J Pharm Policy Pract. 2015 May 11;8(1):18
pubmed: 25995847
BMJ Glob Health. 2019 Oct 05;4(Suppl 9):e001306
pubmed: 31673436
Pediatric Health Med Ther. 2021 Aug 14;12:421-429
pubmed: 34429684
Int J Environ Res Public Health. 2020 Jun 09;17(11):
pubmed: 32527067
BMC Pharmacol Toxicol. 2015 Dec 23;16:43
pubmed: 26699711
Trends Parasitol. 2002 May;18(5):224-30
pubmed: 11983604
BMC Med Inform Decis Mak. 2020 Sep 11;20(1):221
pubmed: 32917201
BMJ Open. 2021 Aug 3;11(8):e051465
pubmed: 34344685
PLoS One. 2018 Oct 25;13(10):e0205977
pubmed: 30359408
N Engl J Med. 2022 Apr 7;386(14):1385-1386
pubmed: 35388682
BMC Pregnancy Childbirth. 2018 Nov 29;18(1):464
pubmed: 30497441
Int J Pediatr. 2020 May 31;2020:3505672
pubmed: 32565833